On the other hand, many different compounds may be used to target EAG1; however, for the purposes of this study we chose astemizole, given its well-known in vitro and in vivo antiproliferative effects on tumor cells through blocking ion currents[11, 17, 23, 32]. Here, KCNH1 is linked to neoplasm.